- Home
- JBI vs GHRS Comparison
JBI vs GHRS Comparison
Compare JBI & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBI
- GHRS
- Stock Information
- Founded
- JBI 2002
- GHRS 2018
- Country
- JBI United States
- GHRS Ireland
- Employees
- JBI N/A
- GHRS N/A
- Industry
- JBI Building Products
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- JBI Industrials
- GHRS Health Care
- Exchange
- JBI Nasdaq
- GHRS Nasdaq
- Market Cap
- JBI 924.6M
- GHRS 849.8M
- IPO Year
- JBI N/A
- GHRS 2021
- Fundamental
- Price
- JBI $7.96
- GHRS $12.31
- Analyst Decision
- JBI Buy
- GHRS Strong Buy
- Analyst Count
- JBI 6
- GHRS 8
- Target Price
- JBI $9.80
- GHRS $30.63
- AVG Volume (30 Days)
- JBI 1.3M
- GHRS 187.6K
- Earning Date
- JBI 08-06-2025
- GHRS 05-08-2025
- Dividend Yield
- JBI N/A
- GHRS N/A
- EPS Growth
- JBI N/A
- GHRS N/A
- EPS
- JBI 0.35
- GHRS N/A
- Revenue
- JBI $919,800,000.00
- GHRS N/A
- Revenue This Year
- JBI N/A
- GHRS N/A
- Revenue Next Year
- JBI $5.69
- GHRS N/A
- P/E Ratio
- JBI $22.51
- GHRS N/A
- Revenue Growth
- JBI N/A
- GHRS N/A
- 52 Week Low
- JBI $5.99
- GHRS $6.00
- 52 Week High
- JBI $15.24
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- JBI 47.64
- GHRS 52.37
- Support Level
- JBI $7.83
- GHRS $12.43
- Resistance Level
- JBI $8.85
- GHRS $13.15
- Average True Range (ATR)
- JBI 0.25
- GHRS 0.99
- MACD
- JBI -0.08
- GHRS -0.14
- Stochastic Oscillator
- JBI 13.06
- GHRS 41.03
About JBI Janus International Group Inc.
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. The Janus International segment is comprised of a subsidiary whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.